Article Information
History
- March 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Xiang Gao1,¶,
- Hui Cao2,¶,
- Liang Zhou3,¶,
- Xiaopan Li4,
- Yongbin Zou5,
- Dehua Yu6,
- Jinsong Geng7,
- Haiyi Jia8,
- Yipeng Lv9,
- Wenya Yu10,
- Yichen Chen11,
- Zhaoxin Wang12,*,
- Jianwei Shi13,* and
- Hua Jin14,*
- 1School of Public Health, Shanghai Jiaotong University, Shanghai, China
- 2Department of Oncology, Chenzhou First People’s Hospital, Hunan, China
- 3School of Public Health, Shanghai Jiaotong University, Shanghai, China
- 4Center for Disease Control and Prevention, Pudong New Area, Shanghai, China; Fudan University Pudong Institute of Preventive Medicine, Pudong New Area, Shanghai, China
- 5Department of Oncology, Chenzhou First People’s Hospital, Hunan, China
- 6Academic Department of General Practice, School of Medicine, Tongji University, Shanghai, China; Department of General Practice, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, China; Shanghai General Practice and Community Health Development Research Center, Shanghai, China
- 7Medical School of Nantong University, Nantong, China
- 8Zhongshan Hospital of Fudan University, Shanghai, China
- 9School of Public Health, Shanghai Jiaotong University, Shanghai, China
- 10School of Public Health, Shanghai Jiaotong University, Shanghai, China
- 11Center for Disease Control and Prevention, Pudong New Area, Shanghai, China; Fudan University Pudong Institute of Preventive Medicine, Pudong New Area, Shanghai, China;
- 12School of Public Health, Shanghai Jiaotong University, Shanghai, China
- 13School of Public Health, Shanghai Jiaotong University, Shanghai, China
- 14Academic Department of General Practice, School of Medicine, Tongji University, Shanghai, China; Department of General Practice, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, China; Shanghai General Practice and Community Health Development Research Center, Shanghai, China;
- ↵*These authors are co-corresponding authors on this work: Zhaoxin Wang: supercell002{at}sina.com; Jianwei Shi: shijianwei_amy{at}126.com; Hua Jin: rjinhua{at}tongji.edu.cn.
Posted March 13, 2022.
Comparing survival in urinary tract cancer patients with various second primary malignancies: A population-based study
